Results 111 to 120 of about 573 (176)

Nitisinone desensitization protocol, case report of hereditary Tyrosinemia type 1 with successful treatment and outcomes. [PDF]

open access: yesOrphanet J Rare Dis
Vallejo M   +6 more
europepmc   +1 more source

A Comprehensive In Vitro and In Silico Approach for Targeting 4-Hydroxyphenyl Pyruvate Dioxygenase: Towards New Therapeutics for Alkaptonuria. [PDF]

open access: yesInt J Mol Sci
Bernardini G   +8 more
europepmc   +1 more source

Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. [PDF]

open access: yesJ Cell Mol Med, 2023
Bai L   +9 more
europepmc   +1 more source

Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines. [PDF]

open access: yesJ Inherit Metab Dis
Kuypers AM   +5 more
europepmc   +1 more source

Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria. [PDF]

open access: yesNutrients
Ranganath LR   +11 more
europepmc   +1 more source

TolCV1 inhibition by NPPB renders <i>Vibrio vulnificus</i> less virulent and more susceptible to antibiotics. [PDF]

open access: yesAntimicrob Agents Chemother
Gong Y   +7 more
europepmc   +1 more source

Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1. [PDF]

open access: yesHepatol Commun
Ates I   +13 more
europepmc   +1 more source

Antifungal activity against Candida albicans of methyl 3,5-dinitrobenzoate loaded nanoemulsion. [PDF]

open access: yesBraz J Microbiol
Duarte ABS   +6 more
europepmc   +1 more source

New Insights into the <i>In Situ</i> Fenton-like Process by Copper(II)-hydroxylamine Coupling: Reactive Species, Applications, and Limitations. [PDF]

open access: yesACS ES T Water
Pellegrino S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy